Anymedi Inc.

Analysis

Anymedi Inc. currently has 1 pending office action in its patent portfolio. This prosecution activity is handled by 1 distinct examiner, indicating a singular point of contact for the company's current legal matters. Interestingly, the data reports 0 distinct art units associated with this activity, which may reflect a specific administrative status or a unique classification phase for the pending application. The focus of the company's current efforts remains entirely on this single outstanding action.

The busiest examiner for the portfolio is KOROMA, SORIE IBRAHIM, who is currently managing 1 busiest examiner pending office action. Since there is 1 distinct examiner involved, KOROMA, SORIE IBRAHIM is responsible for the company's pending workload. This concentration means that the outcome of the current prosecution efforts rests with the decisions and review process of this one individual. The relationship between the examiner's pending load and the total pending actions underscores the narrow scope of the current portfolio.

Practitioners managing the portfolio must tailor their approach specifically to the preferences and requirements of the busiest examiner. With 1 pending office action and 1 distinct examiner, there is no diversification of examiner perspective across the portfolio. The presence of 0 distinct art units further emphasizes the unique or highly focused nature of the current prosecution environment for the company and its 1 busiest examiner pending action.